Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
19.86
+0.21 (1.09%)
Jul 30, 2026, 2:13 PM EDT - Market open
Fulgent Genetics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 564 | 816 | 570 | 857 | 877 | 3,034 | |
Market Cap Growth | 2.79% | 43.34% | -33.55% | -2.21% | -71.10% | 106.65% |
Enterprise Value | -33.93 | 475.62 | 307.87 | 431.48 | 359.26 | 2,597 |
Last Close Price | 19.86 | 26.27 | 18.47 | 28.91 | 29.78 | 100.59 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 6.43 | 6.14 |
Forward PE | - | 247.16 | 247.16 | 247.16 | 247.16 | 13.80 |
PEG Ratio | - | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
PS Ratio | 1.75 | 2.53 | 2.01 | 2.96 | 1.42 | 3.06 |
PB Ratio | 0.54 | 0.73 | 0.50 | 0.75 | 0.69 | 2.62 |
P/TBV Ratio | 0.73 | 0.85 | 0.57 | 0.89 | 0.95 | 2.91 |
P/FCF Ratio | - | - | - | 178.75 | 3.73 | 5.89 |
P/OCF Ratio | - | - | 27.05 | 31.75 | 3.46 | 5.63 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | - | 1.47 | 1.09 | 1.49 | 0.58 | 2.62 |
EV/EBITDA Ratio | - | - | - | - | 1.70 | 3.78 |
EV/EBIT Ratio | - | - | - | - | 2.01 | 3.84 |
EV/FCF Ratio | - | - | - | 89.97 | 1.53 | 5.04 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / EBITDA Ratio | - | - | - | - | 0.03 | 0.01 |
Debt / FCF Ratio | - | - | - | 0.25 | 0.02 | 0.01 |
Net Debt / Equity Ratio | -0.26 | -0.30 | -0.23 | -0.37 | -0.41 | -0.38 |
Net Debt / EBITDA Ratio | 3.38 | 5.01 | 5.26 | 2.50 | -2.46 | -0.65 |
Net Debt / FCF Ratio | 2.46 | 2.70 | 13.38 | -88.19 | -2.22 | -0.86 |
Asset Turnover | 0.27 | 0.27 | 0.23 | 0.22 | 0.46 | 1.00 |
Quick Ratio | 3.83 | 4.95 | 4.49 | 6.51 | 6.57 | 5.60 |
Current Ratio | 5.31 | 6.48 | 4.85 | 6.96 | 7.13 | 5.81 |
Return on Equity (ROE) | -6.97% | -5.51% | -3.87% | -14.58% | 11.65% | 58.35% |
Return on Assets (ROA) | -7.96% | -6.59% | -5.08% | -15.02% | 10.33% | 50.68% |
Return on Invested Capital (ROIC) | -12.25% | -9.76% | -7.88% | -26.97% | 18.72% | 101.16% |
Return on Capital Employed (ROCE) | -9.65% | -8.01% | -6.40% | -15.90% | 14.45% | 77.53% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | - | - | - | - | 15.55% | 16.28% |
FCF Yield | - | - | - | 0.56% | 26.78% | 16.97% |
Buyback Yield / Dilution | -0.95% | -1.79% | -1.51% | 3.81% | 0.04% | -28.77% |
Total Shareholder Return | -0.95% | -1.79% | -1.51% | 3.81% | 0.04% | -28.77% |